Arrowhead Research | ARWR - القيمة السوقية





القيمة السوقية تغيير تاريخ
Agios Pharmaceuticals USD 2.01B 423M 2026-03
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Anika Therapeutics USD 139M 3M 2025-12
Arrowhead Research USD 8.78B 236M 2026-03
Heron Therapeutics USD 238M 7M 2025-12
Incyte USD 18.73B 660M 2026-03
Ionis Pharmaceuticals USD 12.46B 356M 2026-03
Ligand Pharmaceuticals USD 3.98B 241M 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Nektar Therapeutics USD 12.82B 11.96B 2026-07
Novartis USD 307.76B 15.54B 2026-03
Sarepta Therapeutics USD 2.28B 30M 2026-03
TG Therapeutics USD 5.31B 572M 2026-03
Ultragenyx Pharmaceutical USD 2.06B 159M 2026-03
Vertex Pharmaceuticals USD 113.58B 1.44B 2026-03
Xencor USD 893M 200M 2026-03